| Autor: |
Buján Bonino C; Department of Dermatology, University Hospital of Santiago de Compostela, 36001 Santiago de Compostela, Spain., Rodríguez-Blanco I; Department of Dermatology, University Hospital of Santiago de Compostela, 36001 Santiago de Compostela, Spain., Sánchez-Aguilar Rojas D; Department of Dermatology, University Hospital of Santiago de Compostela, 36001 Santiago de Compostela, Spain., Vázquez Veiga HA; Department of Dermatology, University Hospital of Santiago de Compostela, 36001 Santiago de Compostela, Spain., Flórez Á; Department of Dermatology, University Hospital of Pontevedra, 36162 Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), Servizo Galego de Saúde-Universidade de Vigo (SERGAS-UVIGO), 36213 Vigo, Spain. |
| Abstrakt: |
The use of topical and intralesional immunotherapy in the treatment of cutaneous malignant neoplasia in sensitive areas such as the lips and eyelids is discussed. Surgery may not be feasible or may result in deformities in these areas, making alternative treatment options necessary. A narrative literature review was conducted using MEDLINE (PubMed) as the main literature database, collecting available evidence of experiences with various topical and intralesional therapies in the aforementioned anatomical locations, ranging from case reports to clinical trials. The clearance rates and potential adverse reactions of therapeutic options such as imiquimod 5%, 5-fluorouracil (5-FU), photodynamic therapy (PDT), ingenol mebutate (IM), diclofenac, intralesional methotrexate, and interferon are reviewed. Although limited by their heterogeneity and the scarcity of clinical trials, these studies point towards promising response rates and minimal adverse effects, making these treatments viable options in selected cases. |
